A major driver of the opioid crisis gripping the U.S. has been Opioid Withdrawal Syndrome (OWS). A common misconception is that only “addicts” experience symptoms of OWS when they can’t obtain opioids. The truth: Anyone who uses opioids regularly, even when legitimately prescribed opioids for pain relief, will develop physical dependence to them. While no approved non-opioid prescription treatment for the mitigation of OWS was on the market, our client, US WorldMeds, seized the opportunity to change that with the launch of LUCEMYRA™.

Click here to read about their successful brand launch that has already changed the dynamic of OWS management.

More news